Nasal polyps affect approximately 1-4% of the general population worldwide, with higher rates among those with chronic rhinosinusitis, according to the National Institutes of Health. These soft, noncancerous growths develop in the lining of the nasal passages and sinuses, disrupting normal breathing and smell. Because symptoms often develop slowly, many cases remain undiagnosed until the polyps have already caused significant discomfort. This delay in detection makes effective management of this chronic condition particularly challenging for patients and healthcare professionals alike.
Health
41. The Role of Immunotherapy Immunotherapy, commonly known as “allergy shots,” may offer an additional strategy for managing nasal polyps in individuals whose symptoms are driven…